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Summary
Long-term complications and accelerated progression of atherosclerosis result in
subsrantial morbidiry and mortality in patients with type I (insulin-dependent) and
type 2 (non-insulin-dependent) diabetes mellitus. Microcirculatory abnormalit ies
contribute to the pathogenesis of nephropathy, retinopathy, neufoPathy and foot disease
in diabetes. Numerous factors and processes have been identified to play a role in the
parhogenesis of microvascular alterations that contribute to the development of long-
term complications. Capil lary hypertension and hyperperfusion ('the haemodynamic
hypothesis ' ) ,  a  reduct ion in  heparan sulphate proteoglycan content  of  basement
membranes ('the Steno hypothesis') and endothelial dysfunction have been identified as
major contriburors ro the onset and progression of microangiopathy in diabetes mellitus.
Early in the onset of diabetic nephropathy and retinopathy, increased microvascular
permeabil ity can be demonstrated both locally and systemically. Microalbuminuria can
bc regarded as a renal expression of increased microvascular permeability.
This thesis  focuses on rhe in terre lat ionship between increased microvascular
permeabii ity and determinants of the haemodynamic and Steno hypotheses, as well as
endothelial function. The ultimate goai is to contribute to the insight of early alterations
in microvascular  permeabi l i ty  that  are re lated to the development  of  long- term
complications in diabetes mellitus.
Several  rechniques can provide parameters of  microvascular  permeabi l i ty .  The
rranscapil lary permeabil ity of sodium fluorescein in the skin was used in our studies, as
this technique does not require the injection of radioactive substances, provides anatomical
data of the site of measuremenr and allows simultaneous local blood flow measurement.
In parients with the growth hormone deficiency syndrome, l imited data is available on
microcirculatory characteristics. There is evidence that the growth hormone - insulin-
l ike growth factor-l axis influences systemic and renal microvascular permeabil ity, and
has a role in the regulation of angiogenesis. The effects of growth hormone deficiency
and suppletion rherapy on microvascular permeabil ity are unknown. Recentiy, it has
been suggested that even minor alterations in renal protein handling are related to
increased cardiovascular isk. Therefore, there is some concern about the effect of growth
hormone replacement therapy on urinary protein handling.
Chapter 2 evaluates the reproducibility of the transcapillary le:rkage of sodium fluorescein
as determined by the 'large window' videodensitometry method in our vascular laboratorv.
We propose ro Llse the average relative fluorescence light intensity over the first 7 minutes
of the videodensitometry (1""(7min)), as this parameter offers the best combination oF
reproducibil i ty and the power to discriminate type t diabetic subjects from healthy
subjects. Furthermore, we introduce a computerized system to generate the fluorescence
light intensiry curves. These modifications recluced the day-to-day coefficie r.rt of variation
to 10%o.
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So far, the transcapillary leakage of sodium fluorescein has only been documented in
mixed populations of type I and type 2 diabetic patients, by a single-capil lary technique
that is probably not suited for intervention studies. Chapter 3 relates the transcapillary
leakage of sodium fluorescein to the presence or absence of microalbuminuria, a classical
parameter of increased microvascular permeabiliry. Ten normoalbuminuric rype I diabetic
Patients were compared with 10 microalbuminuric type 1 diabe tic patients and with I 0
healthy control subjects. To avoid influences of ambient glucose level, all measuremenrs
were performed at a biood glucose level of 5 mmol/L. Tianscapil lary sodium fluorescein
leakage was increased in the normoalbuminuric parients, as compared to the control
subjects. The increase was even more marked in the patients with microalbuminuria.
The finding of an increased skin capil lary permeabil ity in the normoalbuminuric parients
marks a fur.rdamental difference between this parameter and other measures of caoillarv
permerrb i l i ty  (TER albumin,  c lp i l lary f i l t rar ion coef f ic icnt  ) .and paramcrers oFcndor hel ia l
dysfunction, as all these parameters are usually reported to be normal in normoalbr-rminuric
type I diabetic subjects with a long disease duratior.r. In theory, the increase in sodium
fluorescein leakage in the normoalbuminuric patients could reflect haemodynamic
alterations, related to the higher plasrna insulin level as compared ro the healthy subjects.
Also, the relatively small size of the flr.roresccin molecule, a.s compared to albumin, could
explain the rcported differences with other parameters oÍ microvascular permeabil itv.
The microalbuminuric prrrients werc rcsrudied after 6 weeks rrcarmenr with the
ACE-inhibitor enalapril, l0mg once dailv. This treatnlent clid not onlv reduce mcan
arterial blood pressure and urinary albumin cxcretion, but importantly, transcapil larv
sodir,rm fluoresccin leakage was reduced. Large window videodensitometry with sodium
fluorescein scems a useful tool to document capil lary pcrmeabil ity in inrervention studies.
The eflects of acute hyperglycaenria nd hyperinsulinaemia on transcapil lary sodium
flttorcscein le:rkagc are evaluated in chapter 4. Sixteerr tvpc I diabetic subjects without
long-term cornplications were sttrdiccl cluring 4 dilfcrent glr-rcosc clamps. Hvpcrglyc:remia
and hyperinsulinaerlia, Lroth separately as well as in combination, induced an increase
in skin blood flow, without an increase in capil larv density. There were ncl eflècts on
t ra r r s tep i l l r r y  l cekage  o l ' soc l i t r n r  f l uo rescc in  and  o r r ' p ; r r r r r r r t c r s  o t ' en . l o rhc l i a l  l unc r i t , n .
Soluble intercellular adhesion molecule- I (slCAM- 1) and vor-r Willebrand fàctor antigen
(vWF) ievels were trsecl as pararnerers of endothelial f irnction.
\i/e cor.rclude that microvascular permeabil itv in nornroalbtrminuric type I cliabetes
nrell ittrs is primarily dcterrl ined by properties of the capil lary wall, and'nor by rrcure
chanses in local h:remodynamics. Furthcrmore, the vasodilatory effects of hypergll,caerni:r
ancl hypcrinsulinaemia cor.rlcl contribute to long-tcrrn vascul:rr altcrations, as suggested
by thc haemodynar.nic hvpothesis.
Chapter 5 describes thc same qLresri()n i  rvpe 2 diabetes. Nine typc 2 diabetic subjects
underwent three separatc glucose clarnps. ' lwo hvperinsulinaemic glucose cl:rm;rs, one
dur ins normoglvcaemia and one dur ing hyperglyc i rcmia,  were con' rpared wi th a
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normogiycaemic glucose clamp with low insulin levels. A hyperglycaemic glr-rcose clampr
rvith low insulin levels was not performed, as this would require pharmacoioeical
suppression of endogenous insr-rl in secretion, an intervention that could theorerically
exert effects of its own. Hyperinsulinaemia, both with and without concomirant
hyperglycaemia, did not incluce a change in transcapil lary leakage of sodium fluorescein,
skin blood flow or capil lary density. Circulating parameters of endothelial function,
sICAM-1 and v\W'F, were not elevated by hyperinsulinaemia, with or without hyper-
glvcaernia. sICAM-1 ar-rd vWF ler.els were negatively correlated with insulin sensiriviry,
indicating the highest levels in the least insulir.r-sensitive subjects. In contrast, transcapillary
leakase of soclium fluorescein, skin blood flow and skin capil lary der-rsity did not correlate
with insulin sensitivity.
These data show that also in type 2 diabetic subject.s, acute hyperinsulinaemia rloe.s
not induce an increase in sodium fluorescein leakage or paramerers of endothelial function.
l'he vasodilatory effect of hyperinsulinaemia that r.l'as observecl in the skin of rvpe I
diabetic subjects could not tre reproduced in type 2 diabetic subjects. F-urthermore, these
data suggest hat the coexistence of hvperinsulinaenria nd endotheli,r l dysfunction in
rype 2 diabetes mellitr-rs does not indicate a causal relationship, but mal.rather indicate
a decreased insLrlin sensitivity as a common underlyine cause .
I n chapter 6, the relationship benveen microv:rscular hyclrostatic pressure and permeabiliry
is stuclied in 12 healtl-rv corrtrol subjects. An acute increase in microvascular pressure,
induced by partial venous occlusion, did not increase the trirnscapil larl '  pernreabil ity of
sodiurn fluorescein. Ve cor-rclude that an increased microvascular pem.reabil ity is not
neLe\sar i ly  a d i rcct  ref lcct ion o l ' increased c. tp i l lary hy. l rosrr r t ic  pr" r rur . .  Thi ,  expl ic i r ly
cloes r.rot nrle out the possibil i ty that a chror.ric increase in c:rpil lari, pressure could sti l l
induce structural microvasculal alterations that could eventually lead to incrcased
microva.scul a r perm eabilitv.
1i'anscapillary, leakage of sodium fluorescein :rnd capillary density rvere studied in chaprer 7
before and aftcr I 2 months of grorvth hormone replacement herapy in 7 growth hormone
deficient adults. E,ach patient rvas matched with two heakl-ry control subjecrs. Borh
capil larv permeabil ity and capil lary density were lower in untreated growth hormone
deficiency patients as compared to control subjects. Growth hormone replacemenr tl.rerapy
r.rormaliz-ed plasrna insulin-l ike srowth factor-1, capil lary permeabil itv and capil lary
density. This is the first stuc{y to c{ocutnent that the growth hormonc deficiency syndrome
is associatccl with microvascular alterations, which are responsive to growth hormone
replacement therapy.
' l 'he 
cffect of 6 months gro$'th hormone replacement therapy on urinary protein handling
in 24 grou,th hormone deficiet.rt adults is evalu;rted in chapter 8. Growth hormone
increased plasma insulin-like growth factor- I , without a significant effect on mean urinary
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,t effect on mean urinary
blood pressure . Grorvth
hormone replacement, aimed at increasing insulin-l ike growth factor-1 levels to within
the physiological range, does not result in a clinically relev:rnt increase in urinary protein
excretion. However, individual responses in insulin-l ike growth factor- I levels correlated
positively with changes in urinary alburlin excretion, which supports the ratioÍ'rale to
avoid supraphysiological insulin-l ike growth factor-1 levels.
Future perspect ives
This thesis studies practical ar.rd theoretical considerations regarding the interpretàtion
of microvascular permeabil iry studies with sodium fluorescein in diabetes mellitus and
in the growth hormone deficiency syndrome. Future stuclies could address the following
questions:
* FIow does skin microvascular permeebil ity relate to capil lary hydrostatic pressure , as
assessed by direct micropuncture oIskin capil laries in vivo?
* \7[rat biochemical abnornralit ies cause the haemodynarnic hanges observed in type
I diabetic patients? Can they be pharrnacologically inf'luenced, and would that reduce
the incidence of long-term complicarions?
* What is the prospective value of microvascular permeability with regard to the
development of long-term complications in diabetes mellitus?
* Do the reduced capil lary densiry and permeabil ity in the skin of patients with the
growth hormone deficiency syndrome relate to reduced muscle capil lary densitr ',
oxygen disposal and physical performance?
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